Sort

Search

01/07/2024 Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study
Manzanares, RG, Gamez, MA, Garcia, JM, Orna, JAG, Perez, AP, Barrios, V, Padial, LR, Sanchez, MMPA. Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024 Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Pascual-Corrales, E, Berrocal, VR, Guerrero-Pérez, F, Vicente, A, Hualpa, JCP, García-Centeno, R, González-Fernández, L, García, MDO, Echarri, AI, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar-Taibo, R, Bernabéu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jiménez, C, Galiana, PA, Venegas, E, González-Molero, I, Iglesias, P, Blanco-Carrera, C, De Lara, FVO, Novoa, PD, Mezquita, EL, Hanzu, FA, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Asla, Q, Gimeno, PG, Recio-Córdova, JM, Avilés-Pérez, MD, Asensio-Wandosell, D, Sampedro-Núñez, M, Cámara, R, Fano, MP, Ruz-Caracuel, I, Fajardo, C, Marazuela, M, Puig-Domingo, M. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs. ENDOCRINE-RELATED CANCER. 2024; 31(7)DOI:10.1530/ERC-24-0043. PMID:38713182. IF:4.600(Q1/3D).
01/07/2024 Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Ruiz-Cobo, JC, Llaneras, J, Forns, X, Moya, AG, Amiel, IC, Arencibia, A, Diago, M, Garcia-Samaniego, J, Castellote, J, Llerena, S, Rodriguez-Seguel, E, Mateos, B, Rodriguez, M, Zabal, JMR, Fernandez, I, Calleja, JL, Morillas, RM, Montoliu, S, Andrade, RJ, Aranda, EB, Hernandez-Guerra, M, Mate, CJ, Gonzalez-Santiago, JM, de Cuenca, B, Bernal-Monterde, V, Delgado, M, Turnes, J, Lens, S, Buti, M. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 60(2)DOI:10.1111/apt.18020. PMID:38695095. IF:6.700(Q1/1D).
01/07/2024 Genetic Diversity of Trypanosoma cruzi in the United States of America: The Least Endemic Country for Chagas Disease
Llovera, A, Abras, A, Fernández-Arévalo, A, Ballart, C, Heras, S, Muñoz, C, Gallego, M. Genetic Diversity of Trypanosoma cruzi in the United States of America: The Least Endemic Country for Chagas Disease. Life-Basel. 2024; 14(7)DOI:10.3390/life14070901. PMID:39063654. IF:3.400(Q1/3D).
01/07/2024 CD66b+/CD68+ circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection
Suades, R, Greco, MF, Prieto, P, Padro, T, Devaux, Y, Domingo, P, Badimon, L. CD66b+/CD68+ circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection. Journal of Extracellular Vesicles. 2024; 13(7)DOI:10.1002/jev2.12456. PMID:39007437. IF:14.500(Q1/1D).
01/07/2024 Non-inferior efficacy and less weight gain when switching to DTG/3TC than when switching to BIC/FTC/TAF in virologically suppressed people with HIV (PWH): the PASO-DOBLE (GeSIDA 11720) randomized clinical trial
Ryan, P, Blanco, JL, Masia, M, Garcia-Fraile, L, Crusells, MJ, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, J, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Manzanares, E, Gil, P, de Miguel, M, Alejos, B, Martinez, E. Non-inferior efficacy and less weight gain when switching to DTG/3TC than when switching to BIC/FTC/TAF in virologically suppressed people with HIV (PWH): the PASO-DOBLE (GeSIDA 11720) randomized clinical trial. Journal of the International AIDS Society. 2024; 27DOI:. PMID:. IF:4.900(Q1/2D).
01/07/2024 Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging
Espinosa, I, D'Angelo, E, Prat, J. Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging. GYNECOLOGIC ONCOLOGY. 2024; 186DOI:10.1016/j.ygyno.2024.04.008. PMID:38615479. IF:4.100(Q1/1D).
01/07/2024 Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview
Badhwar, A, Hirschberg, Y, Valle-Tamayo, N, Iulita, MF, Udeh-Momoh, CT, Matton, A, Tarawneh, RM, Rissman, RA, Ledreux, A, Winston, CN, Haqqani, AS. Assessment of brain-derived extracellular vesicle enrichment for blood biomarker analysis in age-related neurodegenerative diseases: An international overview. ALZHEIMERS & DEMENTIA. 2024; 20(7)DOI:10.1002/alz.13823. PMID:38864416. IF:11.100(Q1/1D).
01/07/2024 Repeat Transurethral Resection (TUR) plus Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study
Soria, F, Rosazza, M, Livoti, S, Dutto, D, Colucci, F, Sylvester, RJ, Shariat, SF, Babjuk, M, Palou, J, Gontero, P. Repeat Transurethral Resection (TUR) plus Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. European Urology Focus. 2024; 10(4)DOI:10.1016/j.euf.2023.10.019. PMID:37923633. IF:5.600(Q1/1D).
01/07/2024 Laser Ablation Efficiency, Laser Ablation Speed, and Laser Energy Consumption During Lithotripsy: What Are They and How Are They Defined? A Systematic Review and Proposal for a Standardized Terminology
Kwok, JL, De Coninck, V, Ventimiglia, E, Panthier, F, Corrales, M, Sierra, A, Emiliani, E, Talso, M, Miernik, A, Kronenberg, P, Enikeev, D, Somani, B, Ghani, KR, Traxer, O, Keller, EX. Laser Ablation Efficiency, Laser Ablation Speed, and Laser Energy Consumption During Lithotripsy: What Are They and How Are They Defined? A Systematic Review and Proposal for a Standardized Terminology. European Urology Focus. 2024; 10(4)DOI:10.1016/j.euf.2023.10.004. PMID:37940392. IF:5.600(Q1/1D).
01/07/2024 "Funducation"-The New Age of Learning, Intersection of Education, and Fun
Hong, JP, Masià, J. "Funducation"-The New Age of Learning, Intersection of Education, and Fun. Archives Of Plastic Surgery-Aps. 2024; 51(04)DOI:10.1055/a-2351-9736. PMID:39034984. IF:(Q/D).
01/07/2024 Experiences of Patients with Breast Cancer Participating in a Prehabilitation Program: A Qualitative Study
Casanovas-alvarez, A, Sebio-Garcia, R, Masià, J, Mateo-Aguilar, E. Experiences of Patients with Breast Cancer Participating in a Prehabilitation Program: A Qualitative Study. Journal of Clinical Medicine. 2024; 13(13)DOI:10.3390/jcm13133732. PMID:38999298. IF:2.900(Q1/2D).
01/07/2024 The growth of Spanish universities teaching the Degree in Human Nutrition and Dietetics: a call for reflection
Pérez-Armijo, P, Pérez-Esteve, E, Perez-López, A, Gamero, A, Troncoso-Pantoja, C, García-Galbis, MR, Fernández-Villa, T, Lozano-Lorca, M, Kouiti, M, Apolinar-Jimenez, E, Nava-González, EJ, Daga, R, Almendra-Pegueros, R. The growth of Spanish universities teaching the Degree in Human Nutrition and Dietetics: a call for reflection. Revista Espanola De Nutricion Humana Y Dietetica. 2024; 28(3)DOI:10.14306/renhyd.28.3.2318. PMID:. IF:(Q/D).
01/07/2024 Analysis of the inclusion of study design in the titles of articles published in the Spanish Journal of Human Nutrition and Dietetics during the period 2022-2024
Lozano-Lorca, M, Gamero, A, Nava-González, EJ, García-Galbis, MR, Fernández-Villa, T, Pérez-López, A, Pérez-Armijo, P, Kouiti, M, Pérez-Esteve, E, Almendra-Pegueros, R. Analysis of the inclusion of study design in the titles of articles published in the Spanish Journal of Human Nutrition and Dietetics during the period 2022-2024. Revista Espanola De Nutricion Humana Y Dietetica. 2024; 28(3)DOI:10.14306/renhyd.28.3.2317. PMID:. IF:(Q/D).
01/07/2024 Nocturnal Glucose Profile According to Timing of Dinner Rapid Insulin and Basal and Rapid Insulin Type: An Insulclock® Connected Insulin Cap-Based Real-World Study
Gómez-Peralta, F, Valledor, X, Abreu, C, Fernández-Rubio, E, Cotovad, L, Pujante, P, Azriel, S, Pérez-González, J, Vallejo, A, Ruiz-Valdepeñas, L, Corcoy, R. Nocturnal Glucose Profile According to Timing of Dinner Rapid Insulin and Basal and Rapid Insulin Type: An Insulclock® Connected Insulin Cap-Based Real-World Study. Biomedicines. 2024; 12(7)DOI:10.3390/biomedicines12071600. PMID:39062173. IF:3.900(Q1/3D).
01/07/2024 Apolipoproteins in Health and Disease
Ordóñez-Llanos, J, Escolà-Gil, JC. Apolipoproteins in Health and Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(13)DOI:10.3390/ijms25137048. PMID:39000153. IF:4.900(Q1/3D).
01/07/2024 Impact of donor NKG2D and MICA gene polymorphism on clinical outcomes of adult and paediatric allogeneic cord blood transplantation for malignant diseases
Cox, ST, Patterson, W, Duggleby, R, Jones, OJR, Madrigal, JA, Querol, S, Salvador, FR, Mata, MJH, Volt, F, Gluckman, E, Szydlo, R, Danby, RD, Hernandez, D. Impact of donor NKG2D and MICA gene polymorphism on clinical outcomes of adult and paediatric allogeneic cord blood transplantation for malignant diseases. EUROPEAN JOURNAL OF HAEMATOLOGY. 2024; 113(1)DOI:10.1111/ejh.14202. PMID:38511389. IF:2.300(Q2/5D).
29/06/2024 Enhanced Safety Surveillance of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season
de la Cueva, IS, Gerber, JE, Hastie, A, Brotons, C, Panzer, F, Pircon, JY, Talsma, P, Eckermann, T, Nikic, V, Gomez, XM, Alsdurf, H. Enhanced Safety Surveillance of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season. DRUG SAFETY. 2024; 47(11)DOI:10.1007/s40264-024-01456-y. PMID:38949714. IF:3.800(Q1/2D).
29/06/2024 APP dyshomeostasis in the pathogenesis of Alzheimer's disease: implications for current drug targets
Sirisi, S, Sánchez-Aced, E, Belbin, O, Lleó, A. APP dyshomeostasis in the pathogenesis of Alzheimer's disease: implications for current drug targets. Alzheimers Research & Therapy. 2024; 16(1)DOI:10.1186/s13195-024-01504-w. PMID:38951839. IF:7.600(Q1/1D).
28/06/2024 Essential Tremor: Update of Therapeutic Strategies
Gironell, A, Marín-Lahoz, J, Póveda, S. Essential Tremor: Update of Therapeutic Strategies. MEDICINA CLINICA. 2024; 162(12)DOI:10.1016/j.medcli.2023.12.013. PMID:38553256. IF:2.100(Q2/3D).